{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4584/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":1363.0082,"timestamp":1747079999999,"preClose":1285.5831,"halted":0,"volume":24162841,"delay":0,"changeRate":0.060226,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":77.425049,"latestTime":"05-12 16:00:00 EDT","open":1308.1039,"high":1369.1108,"low":1283.6705,"amount":358345639.838504,"amplitude":0.06646,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747143000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.329724,"peRate":-15.083875,"turnoverRate":0.01466,"increases":5,"decrements":1,"flats":0,"marketCap":22218667318,"floatMarketCap":22081641078},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":1369.1108,"amplitude":0.06646,"preClose":1285.5831,"low":1283.6705,"pbRate":"3.329724","latestPrice":1363.0082,"volume":24162841,"delay":0,"open":1308.1039,"prevYearClose":1682.2216,"prevWeekClose":1285.5831,"prevMonthClose":1193.6893,"prevQuarterClose":1184.288,"fiveDayClose":1255.2128,"twentyDayClose":1044.6382,"sixtyDayClose":1284.9092,"secType":"PLATE","market":"US","turnoverRate":0.01466,"peRate":-15.083875,"marketCap":22218667318,"floatMarketCap":22081641078,"timestamp":1747079999999,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":5,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533880795","title":"Teva, Alvotech announce FDA approval of interchangeability for SELARSDI","url":"https://stock-news.laohu8.com/highlight/detail?id=2533880795","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533880795?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:15","pubTimestamp":1746443754,"startTime":"0","endTime":"0","summary":"Teva Pharmaceuticals (TEVA), a U.S. affiliate of Teva Pharmaceutical Industries, and Alvotech (ALVO) announced that the U.S. Food and Drug Administ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-alvotech-announce-fda-approval-of-interchangeability-for-selarsdi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-alvotech-announce-fda-approval-of-interchangeability-for-selarsdi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4588","BK4007","BK4585","ALVO","BK4559","BK4596","TEVA","BK4584","BK4557","BK4139"],"gpt_icon":0},{"id":"2532722880","title":"MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532722880","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532722880?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:05","pubTimestamp":1746129900,"startTime":"0","endTime":"0","summary":"DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 01, 2025  -- MannKind Corporation , announced today that its first quarter 2025 financial results will be released before market open on May 8, 2025.We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, nontuberculous mycobacterial  lung disease, pulmonary fibrosis, and pulmonary hypertension.Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation, depending on the target indication.With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.Please visit mannkindcorp.com to learn more, and follow us on LinkedIn, Facebook, X or Instagram.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mannkind-corporation-hold-2025-first-200500372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0},{"id":"2532077316","title":"Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8","url":"https://stock-news.laohu8.com/highlight/detail?id=2532077316","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532077316?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:30","pubTimestamp":1746102600,"startTime":"0","endTime":"0","summary":"MIAMI, May 01, 2025  -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Thursday, May 8, 2025, at 8:00 a.m. ET to discuss its fiscal 2025 second quarter financial results and to provide a business update.As for secondary clinical endpoints, enobosarm + semaglutide treatment resulted in dose dependent greater loss of fat mass compared to placebo + semaglutide, with the enobosarm 6mg dose + semaglutide group having a 46% greater relative loss of fat mass compared to the placebo + semaglutide group at 16 weeks .Alt","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/veru-report-fiscal-2025-second-123000937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4557","BK4007","VERU","BK4584","BK4183"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":23,"code":"91000000","status":"200"}]}}